Darunavir/ritonavir (DRV/r) is non-inferior to lopinavir/ritonavir (LPV/r) in treatment-naive HIV-infected patients and offers a better safety profile, according to a report in the July 31st issue of AIDS.
Reuters Health Information
Source: http://www.medscape.com/pharmacists?src=rss
Medscape Pharmacists Headlines